Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-03-081596PMID 17475907PMCID PMC1939910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia

  2007cited by this paper
• Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

  2007cited by this paper
• Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

  2006cited by this paper
• Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia

  2006cited by this paper
• Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution

  2005cited by this paper
• Survival Analysis: Techniques for Censored and Truncated Data

  2004cited by this paper
• Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.

  2004cited by this paper
• Comparison of allogeneic bone marrow and peripheral blood stem cell transplantation for aplastic anemia : collaborative study of european blood and marrow transplant group (EBMT) and international bone marrow transplant registry (IBMTR)

  2003cited by this paper
• Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

  2002cited by this paper
• Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.

  2002cited by this paper
• Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

  2001cited by this paper
• Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia.

  2001cited by this paper
• Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.

  2000cited by this paper
• Current status of allogeneic bone marrow transplantation in acquired aplastic anemia.

  2000cited by this paper
• Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.

  2000cited by this paper
• High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen

  1999cited by this paper
• Long-term outcome after marrow transplantation for severe aplastic anemia.

  1998cited by this paper
• Survival Analysis: Techniques for Censored and Truncated Data

  1997cited by this paper
• Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.

  1997cited by this paper
• Primary transplantation of allogeneic peripheral blood stem cell for severe aplastic anemia

  1997cited by this paper
• Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.

  1994cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Donor Age and Pre-Transplant Transfusion Burden Independently Predict GVHD and Relapse-Free Survival (GRFS) in Aplastic Anemia

  2026cites this paper
• Graft Source Choice.

  2025cites this paper
• Future directions in transplantation for aplastic anemia.

  2025cites this paper
• Outcomes of Delayed HLA Haploidentical Transplantation with Peripheral Blood Allografts for High-Risk Patients with Severe Aplastic Anemia.

  2025cites this paper
• Acquired severe aplastic anemia

  2025influential citation
• Outcomes of Matched Sibling and Haploidentical Donors Hematopoietic Stem Cell Transplantation for Pediatric Severe Aplastic Anemia: A Retrospective Multicenter Study.

  2025cites this paper
• Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation in Curing Sickle Cell Disease: A Systematic Review and Meta-Analysis of Single-Arm Studies.

  2025cites this paper
• G-CSF-Primed Peripheral Blood Stem Cell Haploidentical Transplantation Could Achieve Satisfactory Clinical Outcomes for Severe Aplastic Anemia Patients.

  2025cites this paper
• Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center.

  2024cites this paper
• Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations

  2024cites this paper
• Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia

  2024cites this paper
• Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.

  2024cites this paper
• [Acquired severe aplastic anemia in emerging countries: Management from allogeneic hematopoietic cell transplantation indication until post-transplant follow-up SFGM-TC].

  2024cites this paper
• Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

  2024cites this paper
• The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults

  2024cites this paper
• Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).

  2024cites this paper
• Trends in allogeneic hematopoietic cell transplantation survival using population-based descriptive epidemiology method: analysis of national transplant registry data

  2024cites this paper
• Combining post-transplant cyclophosphamide with antithymocyte globulin for graft-versus-host disease prophylaxis in hematological malignancies.

  2023cites this paper
• Hematopoietic stem cell transplantation in Zagreb: the first 40 years

  2023cites this paper
• Retrospective Evaluation of Patients Who Underwent Allogeneic Stem Cell Transplantation for Bone Marrow Failure

  2023cites this paper
• Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management

  2023cites this paper
• Peripheral blood stem cell transplantation vs. bone marrow transplantation for aplastic anemia: a systematic review and meta-analysis

  2023cites this paper
• Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure

  2023cites this paper
• T-cell Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.

  2023cites this paper
• Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population.

  2022cites this paper
• Cancer Immunotherapy Beyond Checkpoint Blockade

  2022cites this paper
• Improving outcomes in scleroderma: recent progress of cell-based therapies

  2022cites this paper
• Retrospective Comparison of Efficacy and Safety of Rabbit Anti-Thymocyte Globulin and Porcine Anti-Lymphocyte Globulin in Patients With Acquired Aplastic Anemia Undergoing Hematopoietic Stem Cell Transplantation From Matched Sibling Donors

  2022influential citation
• Successful outcomes of second hematopoietic stem cell transplantation for graft failure in pediatric patients with severe aplastic anemia

  2022cites this paper
• Choices: peripheral blood or marrow: natural or cloned yeasts

  2022cites this paper
• Allogeneic bone marrow transplantation for aplastic anemia.

  2022cites this paper
• Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia

  2022cites this paper
• Back to the OR.

  2022cites this paper
• Anti-Thymocyte Globulin (ATG)-Free Nonmyeloablative Haploidentical PBSCT Plus Post-Transplantation Cyclophosphamide Is a Safe and Efficient Treatment Approach for Pediatric Acquired Aplastic Anemia

  2022cites this paper
• Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes

  2022cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia: A Single Centre Experience in Malaysia

  2022cites this paper
• Radiation-sparing reduced-intensity unrelated umbilical cord blood transplantation for rare hematological disorders in children

  2021cites this paper
• Outcomes of alternative hematopoietic stem cell transplantation in pediatric aplastic anemia High Failure-free Survival after Unrelated Donor Peripheral Blood Stem Cell Transplantation in Pediatric Severe Aplastic Anemia.

  2021cites this paper
• Fludarabine–Cyclophosphamide-Based Conditioning with Antithymocyte Globulin Serotherapy Is Associated with Durable Engraftment and Manageable Infections in Children with Severe Aplastic Anemia

  2021cites this paper
• Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA

  2021cites this paper
• Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia.

  2021cites this paper
• Outcomes of Bone Marrow Transplantation

  2021cites this paper
• Impact of donor telomere length on survival in patients undergoing matched sibling donor transplantation for aplastic anaemia

  2021cites this paper
• Mixed chimerism and secondary graft failure in allogeneic hematopoietic stem cell transplantation for aplastic anemia.

  2020cites this paper
• Reduced-dose of Posttransplant Cyclophosphamide and Cotransplantation of Peripheral Blood Stem Cells and Human Umbilical Cord-derived Mesenchymal Stem Cells in Severe Aplastic Anemia

  2020cites this paper
• Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

  2020cites this paper
• Comparison of Conventional Cyclophosphamide versus Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched-Related Donor Transplantation

  2020cites this paper
• Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies

  2020cites this paper
• Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia

  2020cites this paper
• Treatment of Severe Aplastic Anemia With Porcine Antihuman Lymphocyte Globulin.

  2020cites this paper
• Graft failure

  2020cites this paper
• Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.

  2020cites this paper
• Hämatologische und onkologische Erkrankungen

  2020cites this paper
• Transplant in Aplastic Anemia Using Combined Granulocyte Colony-Stimulating Factor Primed Blood and Bone Marrow Stem Cells: A Retrospective Analysis.

  2020cites this paper
• Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia

  2020cites this paper
• Outcomes of allogeneic haematopoietic stem cell transplantation for patients with severe aplastic anaemia using the porcine antilymphocyte globulin-containing conditioning regimen

  2020cites this paper
• Aplastic anaemia: Current concepts in diagnosis and management

  2020cites this paper
• ERKRANKUNGEN DES BLUTES UND DES GERINNUNGSSYSTEMS, SOLIDE TUMOREN UND PRINZIPIEN DER INTERNISTISCHEN ONKOLOGIE

  2020cites this paper
• Fludarabine, Campath and Low dose Cyclophosphamide (FCClow) with or without TBI Conditioning Results in Excellent Transplant Outcomes in Children with Severe Aplastic Anemia.

  2020cites this paper
• The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.

  2019cites this paper
• Bone Marrow Failure in Children: Approach to Diagnosis and Treatment

  2019cites this paper
• Aplasia Medular

  2019cites this paper
• Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia due to Bone Marrow Failure; Single Regimen, Single Center Experience of 14 years.

  2019cites this paper
• Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.

  2019cites this paper
• Der Einfluss der Stammzellquelle auf das Therapieergebnis bei HLA-differenter allogener hämatopoetischer Stammzelltransplantation

  2019cites this paper
• Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

  2019cites this paper
• Adult aplastic anemia patients can maintain remission after allogeneic hematopoietic stem cell transplantation in a mixed chimeric state

  2019cites this paper
• Allogeneic HSCT for autoimmune disease: a shared decision

  2019cites this paper
• Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

  2019cites this paper
• Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)

  2019cites this paper
• The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation.

  2019cites this paper
• The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

  2019cites this paper
• Principles of Hematopoietic Stem Cell Transplantation

  2019cites this paper
• Aplastic Anemia Preconditioned with Fludarabine, Cyclophosphamide, and Anti-Thymocyte Globulin

  2019cites this paper
• Partial T-cell depleted peripheral blood stem cell transplantation from HLA-identical sibling donors for patients with severe aplastic anemia.

  2019cites this paper
• Immune responses post haematopoietic stem cell transplant : clinical studies of vaccination and autoimmunity

  2019cites this paper
• Consider Allogeneic Bone Marrow Transplantation for Older, FitPatients with Aplastic Anemia.

  2019cites this paper
• Stem cell transplantation in aplastic anemia: Impact on choices for first line therapy

  2019cites this paper
• Transplant outcome for patients with acquired aplastic anemia over the age of 40: has the outcome improved?

  2018cites this paper
• A Case of Ethosuximide-Induced Aplastic Anemia Successfully Treated with Methylprednisolone Pulse Therapy

  2018cites this paper
• Aplastic Anemia

  2018cites this paper
• Study of Aplastic Anaemia, Etiological Role of Environmental and Genetic Factors in Eastern India-A Review

  2018cites this paper
• Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.

  2018cites this paper
• Bone Marrow Harvesting for HSCT

  2018cites this paper
• Donor Selection for Adults and Pediatrics

  2018cites this paper
• Recent advances and current challenges in allogeneic stem cell transplantation in patients with acquired severe aplastic anemia

  2018cites this paper
• Impact of T‐cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working party

  2018cites this paper
• Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment

  2018cites this paper
• Alternative donor transplants for severe aplastic anemia.

  2018cites this paper
• Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.

  2018cites this paper
• Aplastic Anemia-Diagnostics and Therapy of Acquired Aplastic Anemia

  2018cites this paper
• Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.

  2018cites this paper
• Paediatric amendment to adult BSH Guidelines for aplastic anaemia

  2018cites this paper
• IMPACT OF T-CELL DEPLETION STRATEGIES ON OUTCOMES FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR IDIOPATHIC APLASTIC ANEMIA: A STUDY ON BEHALF OF THE EUROPEAN BLOOD AND MARROW TRANSPLANT (EBMT) SAA WORKING PARTY

  2018cites this paper
• CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

  2017cites this paper
• Rare Bone Marrow Failure Conditions

  2017cites this paper
• 11 Sources of Hematopoietic Stem Cells

  2017cites this paper
• Fludarabine-based reduced intensity regimen for matched related donor hematopoietic stem cell transplantation in acquired severe aplastic anemia.

  2017cites this paper
• Hematopoietic cell transplantation for aplastic anemia

  2017cites this paper
• Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.

  2017cites this paper